For example, there are many drugs available, which may offer a starting point for targeting of the HLA-DQA1/B1 genes such as azathioprine, which is an immunosuppressant already in use to treat rheumatoid arthritis, Crohn's disease and ulcerative colitis. This evidence concerns the gene HLA-DQA1 and ulcerative colitis.